These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33642419)

  • 1. Orthogonal antibody testing for COVID-19 among healthcare workers in a non-epidemic place and time:Japan's Iwate Prefecture, May 18-31, 2020.
    Nakamura A; Sato R; Ando S; Oana N; Nozaki E; Endo H; Miyate Y; Soma J; Miyata G
    Fukushima J Med Sci; 2021 Apr; 67(1):27-32. PubMed ID: 33642419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a nonepidemic region, Japan: A hospital-based study on May, 2020.
    Nakamura A; Ando S; Endo H; Sato R
    J Med Virol; 2021 Jul; 93(7):4608-4611. PubMed ID: 33760273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of over-diagnosis in serological testing. Implications for communications strategies.
    Biggeri A; Forni S; Braga M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic.
    Rodriguez A; Arrizabalaga-Asenjo M; Fernandez-Baca V; Lainez MP; Al Nakeeb Z; Garcia JD; Payeras A
    Int J Infect Dis; 2021 Apr; 105():482-486. PubMed ID: 33647507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological Testing Reveals the Hidden COVID-19 Burden among Health Care Workers Experiencing a SARS-CoV-2 Nosocomial Outbreak.
    Nakagama Y; Komase Y; Candray K; Nakagama S; Sano F; Tsuchida T; Kunishima H; Imai T; Shintani A; Nitahara Y; Kaku N; Kido Y
    Microbiol Spectr; 2021 Oct; 9(2):e0108221. PubMed ID: 34550021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA.
    Thomas SN; Altawallbeh G; Zaun CP; Pape KA; Peters JM; Titcombe PJ; Dileepan T; Rapp MJ; Bold TD; Schacker TW; Arbefeville S; Ferrieri P; Thyagarajan B; Jenkins MK; Karger AB
    Clin Biochem; 2021 Apr; 90():15-22. PubMed ID: 33539808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
    Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
    J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.
    Morris CR; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Hanberry B; Iyer S; Heilman S; Camacho-Gonzalez A; Figueroa J; Manoranjithan S; Leake D; Mendis R; Cleeton R; Chen C; Krieger R; Bush P; Hughes T; Little WK; Suthar MS; Wrammert J; Vos MB
    Int J Infect Dis; 2021 Apr; 105():474-481. PubMed ID: 33722686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers.
    Mullins KE; Merrill V; Ward M; King B; Rock P; Caswell M; Ahlman M; Harris AD; Christenson R
    Clin Biochem; 2021 Apr; 90():23-27. PubMed ID: 33472036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust.
    Grant JJ; Wilmore SMS; McCann NS; Donnelly O; Lai RWL; Kinsella MJ; Rochford HL; Patel T; Kelsey MC; Andrews JA
    Infect Control Hosp Epidemiol; 2021 Feb; 42(2):212-214. PubMed ID: 32746953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria.
    Egger M; Bundschuh C; Wiesinger K; Bräutigam E; Berger T; Clodi M; Dieplinger B
    Clin Chem Lab Med; 2021 May; 59(6):e231-e234. PubMed ID: 33554543
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating a SARS-CoV-2 screening strategy based on serological tests.
    Baccini M; Mattei A; Rocco E; Vannucci G; Mealli F
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):193-199. PubMed ID: 33412810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic.
    Venugopal U; Jilani N; Rabah S; Shariff MA; Jawed M; Mendez Batres A; Abubacker M; Menon S; Pillai A; Shabarek N; Kasubhai M; Dimitrov V; Menon V
    Int J Infect Dis; 2021 Jan; 102():63-69. PubMed ID: 33075539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative SARS-CoV-2 Antibody Screening of Healthcare Workers in the Southern Part of Kyoto City During the COVID-19 Pre-pandemic Period.
    Fujita K; Kada S; Kanai O; Hata H; Odagaki T; Satoh-Asahara N; Tagami T; Yasoda A
    Front Public Health; 2020; 8():595348. PubMed ID: 33365297
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
    Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
    Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.